Product Information
CLOBETASOL 0.05% SOLUTION is a generic product labeled by Quagen Pharmaceuticals LLC, priced at $0.1359 per ML under NDC 70752015304. Its NADAC has been published 188 times since Mar 1, 2023.
FDA first approved this application on Feb 17, 2022. Its Orange Book therapeutic-equivalence code is AT.
Strength
.5 mg/mL
Manufacturer
Quagen Pharmaceuticals LLCNDC
70752015304
Classification
Generic
Dosage Form
SOLUTION
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
CLOBETASOL PROPIONATEApproval Type
Generic (ANDA)
FDA Application
ANDA211240FDA Approved
2/17/2022
TE Code
AT
On Market Since
3/14/2022
Pharmacological Classes
Price Statistics
The NADAC for CLOBETASOL 0.05% SOLUTION has been published 188 times since Mar 1, 2023, and over the history we have for it it has declined 52.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1359 per ML |
|---|---|
| All-time high | $0.3253 (Jun 14, 2023) |
| All-time low | $0.1149 (May 20, 2026) |
| 52-week high | $0.1829 |
| 52-week low | $0.1149 |
| Median price | $0.1850 |
| Average price | $0.1964 |
| Largest weekly change | +25.7% (Nov 22, 2023) |
| Weeks tracked | 188 |
| Tracking since | Mar 1, 2023 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 11% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Quagen Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
clobetasol propionate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLOBETASOL 0.05% SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for CLOBETASOL 0.05% SOLUTION, manufactured by Quagen Pharmaceuticals LLC, is $0.1359 per ML (NDC 70752015304), effective Sep 30, 2026.
How has the price of CLOBETASOL 0.05% SOLUTION changed over time?
Over the history we have for it, the NADAC for CLOBETASOL 0.05% SOLUTION has declined 52.5%. It has been tracked across 188 weekly CMS publications since Mar 1, 2023.
What are the highest and lowest recorded NADAC prices for CLOBETASOL 0.05% SOLUTION?
Since Mar 1, 2023, the NADAC for CLOBETASOL 0.05% SOLUTION has ranged from a low of $0.1149 (May 20, 2026) to a high of $0.3253 (Jun 14, 2023), with a median of $0.1850 per ML.
Are there cheaper alternatives to CLOBETASOL 0.05% SOLUTION?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CLOBETASOL 0.05% SOLUTION, is $0.1204 per ML — about 11% below CLOBETASOL 0.05% SOLUTION.
Who manufactures CLOBETASOL 0.05% SOLUTION?
CLOBETASOL 0.05% SOLUTION (NDC 70752015304) is labeled by Quagen Pharmaceuticals LLC, and CMS classifies it as a generic product.